Abstract
Objective: The combination therapy of gonadotropin-releasing hormone analogues (GnRHa) and recombinant human growth hormone (rhGH) has been used to increase growth in children with premature sexual maturation and attenuated growth. The aim of this report was to study the benefit over cost of combined treatment in girls with central precocious puberty (CPP) and poor height prognosis and in girls with idiopathic short stature (ISS) and early puberty. Should this expensive treatment be given to such patients?
Subjects and methods: Two patient groups were included: five girls with central precocious puberty (CPP) who reached final height (FH) at 16.3±1.2 years and eight girls with ISS who reached FH at 14.7±0.8 years. Patients were treated for 3.5±0.6 years.
Results: In both groups, FH improved significantly; in CPP from –1.3 to –0.5 standard deviation score (SDS) (p=0.030) and in ISS from –2.6 to –1.7 SDS (p=0.012). Only girls with CPP reached their target height (–0.5 vs. –0.6 SDS) (p=0.500).
Conclusions: Both groups had a total height gain of 5 cm. Each centimetre cost about €2700 per patient. This treatment should be considered only in patients with extremely low height prediction and very early pubertal onset.
References
1. Job JC, Toublanc JE, Landier F. Growth of short normal children in puberty treated for 3 years with growth hormone alone or in association with gonadotropin-releasing hormone agonist. Horm Res 1994;41:177–84.Search in Google Scholar
2. Saggese G, Pasquino AM, Bertelloni S, Baroncelli GI, Battini R, et al. Effect of combined treatment with gonadotropin releasing hormone analogue and growth hormone in patients with central precocious puberty who had subnormal growth velocity and impaired height prognosis. Acta Pediatr 1995;84:299–304.Search in Google Scholar
3. Pasquino AM, Municchi G, Pucarelli I, Segni M, Mancini MA. Combined treatment with gonadotropin-releasing hormone analogue and growth hormone in central precocious puberty. J Clin Endocrinol Metab 1999;81:948–51.Search in Google Scholar
4. Tuvemo T, Gustafsson J, Proos LA. Growth hormone treatment during suppression of early puberty in adopted girls. Swedish Growth Hormone Advisory Group. Acta Paediatr 1999;88:928–32.Search in Google Scholar
5. Pucarelli I, Segni M, Ortore M, Arcadi E, Pasquino AM. Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution. J Pediatr Endocrinol Metab 2003;16:1005–10.Search in Google Scholar
6. Mul D, Oostdijk W, Waelkens JJ, Schulpen TW, Drop SL. Gonadotropin releasing hormone agonist treatment with or without recombinant human GH in adopted children with early puberty. Clin Endocrinol (Oxf) 2005;55:121–9.Search in Google Scholar
7. Maniati-Christidi M, Livadas S, Voutetakis A, Tolis G, Dacou-Voutetakis C. Human growth hormone and gonadotropin releasing hormone analog combination therapy increases predicted height in short normal girls. Clin Pediatr (Phila) 2003;42:59–65.Search in Google Scholar
8. Tato L, Saggese G, Cavallo L, Antoniazzi F, Corrias A, et al. Use of combined Gn-RH agonist and rhGH therapy for better attaining the goals in precocious puberty treatment. Horm Res 1995;44:49–54.Search in Google Scholar
9. Volta C, Bernasconi S, Tondi P, Salvioli V, Ghizzoni L, et al. Combined treatment with growth hormone and luteinizing hormone releasing hormone-analogue (LHRHa) of pubertal children with familial short stature. J Endocrinol Invest 1993;16:763–7.Search in Google Scholar
10. Saggese G, Cesaretti G, Barsanti S, Rossi A. Combination treatment with growth hormone and gonadotropin-releasing hormone analogues in short normal girls. J Paediatr 1995;126:468–73.Search in Google Scholar
11. Tanaka T, Satoh M, Yasunaga T, Horikawa R, Tanae A, et al. GH and GnRH analog treatment in children who enter puberty at short stature. J Clin Endocrinol Metab 1997;10:623–8.Search in Google Scholar
12. Lanes R, Gunczler P. Final height after combined growth hormone and gonadotropin-releasing analogue treatment in short healthy children entering into normally timed puberty. Clin Endocrinol (Oxf) 1998;49:197–202.Search in Google Scholar
13. Pasquino AM, Pucarelli I, Roggini M, Segni M. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone. J Clin Endocrinol Metab 2000;85:619.Search in Google Scholar
14. Balducci R, Toscano V, Mangiantini A, Municchi G, Vaccaro F, et al. Adult height in short normal adolescent girls treated with gonadotropin-releasing hormone analogue and growth hormone. J Clin Endocrinol Metab 1995;80:3596–600.Search in Google Scholar
15. Kamp GA, Waelkens JJ, de Muinck Keizer-Schrama SM, Delemarre-van de Waal HA, Verhoeven-Wind L, et al. High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature. Arch Dis Child 2002;87:215–20.Search in Google Scholar
16. van Gool SA, Kamp GA, Visser-van Balen H, Mul D, Waelkens JJ, et al. Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty. J Clin Endocrinol Metab 2007;92:1402–8.Search in Google Scholar
17. Walvoord EC, Pescovitz OH. Combined use of growth hormone and gonadotropin-releasing hormone analogues in precocious puberty: theoretic and practical considerations. Pediatrics 1999;104:1010–4.Search in Google Scholar
18. Toumba M, Bacopoulou I, Savva SC, Skordis N. Efficacy of combined treatment with growth hormone and gonadotropin releasing hormone analogue in children with poor prognosis of adult height. Indian Pediatr 2007;44:497–502.Search in Google Scholar
19. Carel JC, Eugster EA, Rogol A, Ghizzoni L, ESPE-LWPES GnRH Analogs Consensus Conference Group, et al. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 2009;123:752–62.Search in Google Scholar
20. Klein O, Barnes M, Jones V, Feuillan P, Cutler BJ. Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience. J Clin Endocrinol Metab 2001;86:4711–6.Search in Google Scholar
21. Carel JC. Management of short stature with GnRH agonist and co-treatment with growth hormone: a controversial issue. Mol Cell Endocrinol 2006;25:254–5.Search in Google Scholar
22. Wit JM, Rekers-Mombarg LT. Final height gain by GH therapy in children with idiopathic short stature is dose dependent. J Clin Endocrinol Metab 2002;87:604–11.Search in Google Scholar
23. Wit JM, Rekers-Mombarg LT, Cutler GB, Crowe B, Beck TJ, et al. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect. J Pediatr 2005;146:45–53.Search in Google Scholar
24. Stanhope R, Preece MA, Grant DB, Brook CG. New concepts of the growth spurt of puberty. Acta Pediatr Scand 1988;347:30–7.Search in Google Scholar
25. Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist, 2nd ed. Stanford: Stanford University Press, 1959.Search in Google Scholar
26. Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich and Pyle hand standards. J Pediatr 1952;40:423–41.Search in Google Scholar
27. Tanner JM, Goldstein H, Whitehouse RH. Standards for children’s height at ages 2-9 allowing for height of parents. Arch Dis Child 1970;45:755–62.Search in Google Scholar
28. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291–303.Search in Google Scholar
29. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in boys. Arch Dis Child 1970;45:13–24.Search in Google Scholar
30. Brito V, Latronico A, Cukier P, Teles M, Silveira L, et al. Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs. J Clin Endocrinol Metab 2008;93:2662–9.Search in Google Scholar
31. Lazar L, Padoa A, Philip M. Growth pattern and final height after cessation of gonadotropin-suppressive therapy in girls with central sexual precocity. J Clin Endocrinol Metab 2007;92:3483–9.Search in Google Scholar
32. Heger S, Sippell W, Partsch C. Gonadotropin-releasing hormone analogue treatment for precocious puberty. Twenty years of experience. Endocr Dev 2005;8:94–125.Search in Google Scholar
33. Proos LA, Lönnerholm T, Jonsson B, Tuvemo T. Can the TW3 bone age determination method provide additional criteria for growth hormone treatment in adopted girls with early puberty? A comparison of the Tanner-Whitehouse 3 method with the Greulich-Pyle and the Tanner-Whitehouse 2 methods. Horm Res Paediatr 2010;73:35–40.Search in Google Scholar
34. Cohen S, Cosgrove C. Normal at any cost: tall girls, short boys, and the medical industry’s quest to manipulate height. New York: Jeremy P. Tarcher/Penguin, 2009.Search in Google Scholar
©2014 by Walter de Gruyter Berlin Boston
